nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—ADRB1—type 1 diabetes mellitus	0.797	1	CbGaD
Droxidopa—DDC—nerve—type 1 diabetes mellitus	0.00359	0.166	CbGeAlD
Droxidopa—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00304	0.14	CbGeAlD
Droxidopa—PAH—kidney—type 1 diabetes mellitus	0.00216	0.0995	CbGeAlD
Droxidopa—Isoetarine—ADRB1—type 1 diabetes mellitus	0.00193	0.264	CrCbGaD
Droxidopa—Norepinephrine—SLC18A2—type 1 diabetes mellitus	0.00183	0.25	CrCbGaD
Droxidopa—SLC6A2—nerve—type 1 diabetes mellitus	0.00171	0.0789	CbGeAlD
Droxidopa—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00155	0.0715	CbGeAlD
Droxidopa—DDC—nephron tubule—type 1 diabetes mellitus	0.0014	0.0646	CbGeAlD
Droxidopa—DDC—kidney—type 1 diabetes mellitus	0.00123	0.0567	CbGeAlD
Droxidopa—ADRA1B—kidney—type 1 diabetes mellitus	0.000969	0.0447	CbGeAlD
Droxidopa—SLC16A10—nephron tubule—type 1 diabetes mellitus	0.000959	0.0443	CbGeAlD
Droxidopa—Isoprenaline—ADRB1—type 1 diabetes mellitus	0.000801	0.11	CrCbGaD
Droxidopa—Norepinephrine—ADRB1—type 1 diabetes mellitus	0.000742	0.102	CrCbGaD
Droxidopa—SLC16A10—lymphoid tissue—type 1 diabetes mellitus	0.000724	0.0334	CbGeAlD
Droxidopa—ADRB1—cardiovascular system—type 1 diabetes mellitus	0.000704	0.0325	CbGeAlD
Droxidopa—Dopamine—ADRB1—type 1 diabetes mellitus	0.000689	0.0945	CrCbGaD
Droxidopa—Epinephrine—ADRB1—type 1 diabetes mellitus	0.000673	0.0922	CrCbGaD
Droxidopa—Epinephrine—TNF—type 1 diabetes mellitus	0.000639	0.0875	CrCbGaD
Droxidopa—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.00059	0.0273	CbGeAlD
Droxidopa—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000585	0.027	CbGeAlD
Droxidopa—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000556	0.0257	CbGeAlD
Droxidopa—ADRA2C—kidney—type 1 diabetes mellitus	0.000519	0.0239	CbGeAlD
Droxidopa—ADRA2C—pancreas—type 1 diabetes mellitus	0.000515	0.0238	CbGeAlD
Droxidopa—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000468	0.0216	CbGeAlD
Droxidopa—ADRA2A—pancreas—type 1 diabetes mellitus	0.000411	0.019	CbGeAlD
Droxidopa—ADRA1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.7e-05	0.000155	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.68e-05	0.000154	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SST—type 1 diabetes mellitus	2.68e-05	0.000154	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GCG—type 1 diabetes mellitus	2.68e-05	0.000154	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	2.66e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.66e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.66e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.62e-05	0.000151	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.58e-05	0.000148	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.54e-05	0.000146	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SST—type 1 diabetes mellitus	2.53e-05	0.000146	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.52e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.52e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.52e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.5e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.5e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.5e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SST—type 1 diabetes mellitus	2.49e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.48e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.47e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CD80—type 1 diabetes mellitus	2.44e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GCG—type 1 diabetes mellitus	2.44e-05	0.00014	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.44e-05	0.00014	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GCG—type 1 diabetes mellitus	2.42e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.41e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GCG—type 1 diabetes mellitus	2.39e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.38e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.36e-05	0.000136	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.35e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.34e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.34e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.33e-05	0.000134	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—INS—type 1 diabetes mellitus	2.31e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.3e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CAT—type 1 diabetes mellitus	2.29e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.28e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.27e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.27e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.27e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.26e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	2.26e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GCG—type 1 diabetes mellitus	2.26e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.25e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.24e-05	0.000129	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.23e-05	0.000129	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.23e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.22e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.22e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GCG—type 1 diabetes mellitus	2.22e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	2.21e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.21e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.2e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	2.19e-05	0.000126	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CD86—type 1 diabetes mellitus	2.18e-05	0.000126	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.17e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.14e-05	0.000123	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.11e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.1e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.08e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.08e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.07e-05	0.000119	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.07e-05	0.000119	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.07e-05	0.000119	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.06e-05	0.000119	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.06e-05	0.000119	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	2.06e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.05e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.05e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.05e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.03e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.02e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.02e-05	0.000116	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.99e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	1.97e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	1.97e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.97e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.94e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.94e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.92e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.91e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.91e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.9e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.9e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.89e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.89e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.89e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.88e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.88e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.87e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.86e-05	0.000107	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	1.86e-05	0.000107	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.85e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.84e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CD86—type 1 diabetes mellitus	1.84e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.84e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	1.83e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CD86—type 1 diabetes mellitus	1.81e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.79e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.78e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.76e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.76e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.76e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.75e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.75e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.75e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.74e-05	0.0001	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.73e-05	9.96e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.72e-05	9.93e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.72e-05	9.93e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.72e-05	9.91e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.72e-05	9.9e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.72e-05	9.89e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL2—type 1 diabetes mellitus	1.72e-05	9.88e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.71e-05	9.87e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.71e-05	9.84e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.71e-05	9.84e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.71e-05	9.83e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.7e-05	9.79e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.69e-05	9.71e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.68e-05	9.65e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.67e-05	9.62e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.66e-05	9.55e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.63e-05	9.4e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.63e-05	9.39e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.61e-05	9.26e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.61e-05	9.26e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.61e-05	9.25e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.6e-05	9.19e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CD80—type 1 diabetes mellitus	1.59e-05	9.16e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.58e-05	9.11e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.57e-05	9.04e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.56e-05	8.97e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.55e-05	8.93e-05	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.54e-05	8.85e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.53e-05	8.79e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	1.52e-05	8.73e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	1.5e-05	8.66e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.49e-05	8.6e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.45e-05	8.37e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.45e-05	8.35e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.45e-05	8.35e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.45e-05	8.33e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.44e-05	8.31e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	1.44e-05	8.27e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.43e-05	8.22e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.43e-05	8.21e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.42e-05	8.17e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.42e-05	8.16e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.41e-05	8.09e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.4e-05	8.03e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	1.39e-05	8.01e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	1.37e-05	7.89e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	1.36e-05	7.82e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.35e-05	7.76e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.34e-05	7.73e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	1.34e-05	7.73e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—INS—type 1 diabetes mellitus	1.34e-05	7.72e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	1.33e-05	7.66e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.33e-05	7.63e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.33e-05	7.63e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	1.32e-05	7.6e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.32e-05	7.59e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.32e-05	7.59e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.31e-05	7.56e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.31e-05	7.56e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.31e-05	7.52e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.31e-05	7.52e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.3e-05	7.46e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.3e-05	7.46e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.29e-05	7.43e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	1.27e-05	7.3e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	1.25e-05	7.19e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	1.23e-05	7.09e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.23e-05	7.06e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.22e-05	7.05e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.22e-05	7.03e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.21e-05	6.98e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.21e-05	6.95e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.2e-05	6.92e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.2e-05	6.92e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.2e-05	6.89e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.19e-05	6.85e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.18e-05	6.77e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	1.17e-05	6.76e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.13e-05	6.52e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	1.13e-05	6.5e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.12e-05	6.45e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	1.12e-05	6.44e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.12e-05	6.42e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.11e-05	6.4e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.11e-05	6.4e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	1.11e-05	6.38e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.09e-05	6.3e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	1.09e-05	6.28e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	1.08e-05	6.22e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.07e-05	6.17e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.07e-05	6.14e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	1.03e-05	5.93e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.02e-05	5.87e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.02e-05	5.86e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.01e-05	5.83e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.01e-05	5.82e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	1.01e-05	5.81e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.01e-05	5.81e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	1e-05	5.78e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.98e-06	5.75e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2—type 1 diabetes mellitus	9.97e-06	5.74e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.96e-06	5.74e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.92e-06	5.71e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.92e-06	5.71e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.91e-06	5.7e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.72e-06	5.6e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.44e-06	5.44e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	9.43e-06	5.43e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.41e-06	5.42e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.38e-06	5.4e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.29e-06	5.35e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	9.28e-06	5.34e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.23e-06	5.32e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.2e-06	5.3e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.03e-06	5.2e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.57e-06	4.93e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.55e-06	4.92e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.49e-06	4.89e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.39e-06	4.83e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.25e-06	4.75e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	8.24e-06	4.74e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.2e-06	4.72e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.93e-06	4.57e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.81e-06	4.5e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.79e-06	4.49e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.72e-06	4.44e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.67e-06	4.42e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	7.66e-06	4.41e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.62e-06	4.39e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.62e-06	4.39e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.21e-06	4.15e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.1e-06	4.09e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.94e-06	3.99e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	6.57e-06	3.78e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.44e-06	3.71e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.3e-06	3.63e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.99e-06	3.45e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	5.93e-06	3.42e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—type 1 diabetes mellitus	5.86e-06	3.37e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.86e-06	3.37e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	5.54e-06	3.19e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	5.45e-06	3.14e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.84e-06	2.79e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.5e-06	2.59e-05	CbGpPWpGaD
